LA HB508 | 2024 | Regular Session
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Enrolled on May 30 2024 - 75% progression
Action: 2024-06-03 - Sent to the Governor for executive approval.
Text: Latest bill text (Enrolled) [PDF]
Status: Enrolled on May 30 2024 - 75% progression
Action: 2024-06-03 - Sent to the Governor for executive approval.
Text: Latest bill text (Enrolled) [PDF]
Summary
Provides relative to medical and surgical treatments of cancer (EN SEE FISC NOTE SG EX)
Title
Provides relative to medical and surgical treatments of cancer (EN SEE FISC NOTE SG EX)
Sponsors
Roll Calls
2024-05-29 - House - House Vote on HB 508 CONCUR IN SENATE AMENDMENTS (#1499) (Y: 80 N: 4 NV: 0 Abs: 21) [PASS]
2024-05-20 - Senate - Senate Vote on HB 508 FINAL PASSAGE (#989) (Y: 38 N: 0 NV: 0 Abs: 1) [PASS]
2024-04-16 - House - House Vote on HB 508 FINAL PASSAGE (#500) (Y: 82 N: 11 NV: 0 Abs: 12) [PASS]
2024-04-16 - House - House Vote on HB 508 FINAL PASSAGE (#500) (Y: 82 N: 10 NV: 0 Abs: 13) [PASS]
2024-05-20 - Senate - Senate Vote on HB 508 FINAL PASSAGE (#989) (Y: 38 N: 0 NV: 0 Abs: 1) [PASS]
2024-04-16 - House - House Vote on HB 508 FINAL PASSAGE (#500) (Y: 82 N: 11 NV: 0 Abs: 12) [PASS]
2024-04-16 - House - House Vote on HB 508 FINAL PASSAGE (#500) (Y: 82 N: 10 NV: 0 Abs: 13) [PASS]
History
Date | Chamber | Action |
---|---|---|
2024-06-03 | House | Sent to the Governor for executive approval. |
2024-05-30 | House | Enrolled and signed by the Speaker of the House. |
2024-05-29 | Senate | Signed by the President of the Senate. |
2024-05-29 | House | Read by title, roll called, yeas 80, nays 4, Senate amendments concurred in. |
2024-05-22 | House | Scheduled for concurrence on 05/29/2024. |
2024-05-20 | House | Received from the Senate with amendments. |
2024-05-20 | Senate | Rules suspended. Senate floor amendments read and adopted. Read by title, passed by a vote of 38 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled. |
2024-05-15 | Senate | Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage. |
2024-05-14 | Senate | Read by title and referred to the Legislative Bureau. |
2024-05-13 | Senate | Reported favorably. |
2024-04-29 | Senate | Read by title. Recommitted to the Committee on Finance. |
2024-04-24 | Senate | Reported favorably. |
2024-04-17 | Senate | Read second time by title and referred to the Committee on Insurance. |
2024-04-16 | Senate | Received in the Senate. Rules suspended. Read first time by title and placed on the Calendar for a second reading. |
2024-04-16 | House | Read third time by title, roll called on final passage, yeas 82, nays 11. Finally passed, title adopted, ordered to the Senate. |
2024-04-11 | House | Scheduled for floor debate on 04/16/2024. |
2024-04-10 | House | Read by title, amended, ordered engrossed, passed to 3rd reading. |
2024-04-09 | House | Reported with amendments (13-0). |
2024-03-11 | House | Read by title, under the rules, referred to the Committee on Insurance. |
2024-03-01 | House | Under the rules, provisionally referred to the Committee on Insurance. |
2024-03-01 | House | Prefiled. |